LIDOPRO- capsaicin, lidocaine, menthol, and methyl salicylate ointment

Država: Združene države Amerike

Jezik: angleščina

Source: NLM (National Library of Medicine)

Aktivna sestavina:

CAPSAICIN (UNII: S07O44R1ZM) (CAPSAICIN - UNII:S07O44R1ZM), LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987), MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A), METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ)

Dostopno od:

Terrain Pharmaceuticals

INN (mednarodno ime):

CAPSAICIN

Sestava:

CAPSAICIN 0.000325 g in 1 g

Pot uporabe:

TOPICAL

Tip zastaranja:

OTC DRUG

Terapevtske indikacije:

Topical Analgesic Topical Analgesic Topical Analgesic Topical Analgesic Temporarily relieves minor aches and muscles pains associated with: - arthritis - simple back pain - strains - muscle soreness

Status dovoljenje:

OTC monograph not final

Lastnosti izdelka

LIDOPRO- CAPSAICIN, LIDOCAINE, MENTHOL, AND METHYL SALICYLATE OINTMENT
TERRAIN PHARMACEUTICALS
----------
LIDOPRO 4%
METHEMOGLOBINEMIA
Cases of methemoglobinemia have been reported in association with
local anesthetic
use. Although all patients are at risk for methemoglobinemia, patients
with glucose-6-
phosphate dehydrogenase deficiency, congenital or idiopathic
methemoglobinemia,
cardiac or pulmonary compromise, infants under 6 months of age, and
concurrent
exposure to oxidizing agents or their metabolites are more susceptible
to developing
clinical manifestations of the condition. If local anesthetics must be
used in these
patients, close monitoring for symptoms and signs of methemoglobinemia
is
recommended.
Signs and symptoms of methemoglobinemia may occur immediately or may
be delayed
some hours after exposure and are characterized by a cyanotic skin
discoloration and
abnormal coloration of the blood. Methemoglobin levels may continue to
rise; therefore,
immediate treatment is required to avert more serious central nervous
system and
cardiovascular adverse effects, including seizures, coma, arrhythmias,
and death.
Discontinue lidocaine-containing products and any other oxidizing
agents. Depending on
the severity of the symptoms, patients may respond to supportive care,
i.e., oxygen
therapy, hydration. More severe symptoms may require treatment with
methylene blue,
exchange transfusion, or hyperbaric oxygen.
ACTIVE INGREDIENT
Capsaicin 0.0325%
PURPOSE
Topical Analgesic
ACTIVE INGREDIENT
Lidocaine HCL 4%
PURPOSE
Topical Analgesic
ACTIVE INGREDIENT
Menthol 10%
PURPOSE
Topical Analgesic
ACTIVE INGREDIENT
Methyl Salicylate 27.5%
PURPOSE
Topical Analgesic
USES:
Temporarily relieves minor aches and muscles pains associated with:
arthritis
simple back pain
strains
muscle soreness
WARNINGS
FOR EXTERNAL USE ONLY
DO NOT USE
on open wounds, cuts, damaged or infected skin
with bandage or a heating pad
if condition worsens or symptoms persists for more than 7 days
excessive skin irritation occurs
ASK A DOCTOR BEFORE USE I